{
  "generated": "2025-11-05T06:50:51.367266+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/metabolic/omega-3-met-omega-prediab/metabolic/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "MET-OMEGA-PREDIAB_01",
      "year": 2012,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "prediabetes",
      "population": "Adults with prediabetes concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/omega-3-met-omega-prediab-01",
      "url": "https://doi.org/10.1234/omega-3-met-omega-prediab-01",
      "citation": "MET-OMEGA-PREDIAB_01 (2012); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with prediabetes concerns; Outcome: prediabetes; DOI: 10.1234/omega-3-met-omega-prediab-01; Adverse Events: Transient headache."
    },
    {
      "study_id": "MET-OMEGA-PREDIAB_02",
      "year": 2013,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "prediabetes",
      "population": "Adults with prediabetes concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1234/omega-3-met-omega-prediab-02",
      "url": "https://doi.org/10.1234/omega-3-met-omega-prediab-02",
      "citation": "MET-OMEGA-PREDIAB_02 (2013); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with prediabetes concerns; Outcome: prediabetes; DOI: 10.1234/omega-3-met-omega-prediab-02; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "MET-OMEGA-PREDIAB_03",
      "year": 2014,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "prediabetes",
      "population": "Adults with prediabetes concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/omega-3-met-omega-prediab-03",
      "url": "https://doi.org/10.1234/omega-3-met-omega-prediab-03",
      "citation": "MET-OMEGA-PREDIAB_03 (2014); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with prediabetes concerns; Outcome: prediabetes; DOI: 10.1234/omega-3-met-omega-prediab-03; Adverse Events: None reported."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/omega-3-met-omega-prediab-01",
      "study_ids": [
        "MET-OMEGA-PREDIAB_01"
      ],
      "primary_study_id": "MET-OMEGA-PREDIAB_01",
      "url": "https://doi.org/10.1234/omega-3-met-omega-prediab-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/omega-3-met-omega-prediab-02",
      "study_ids": [
        "MET-OMEGA-PREDIAB_02"
      ],
      "primary_study_id": "MET-OMEGA-PREDIAB_02",
      "url": "https://doi.org/10.1234/omega-3-met-omega-prediab-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/omega-3-met-omega-prediab-03",
      "study_ids": [
        "MET-OMEGA-PREDIAB_03"
      ],
      "primary_study_id": "MET-OMEGA-PREDIAB_03",
      "url": "https://doi.org/10.1234/omega-3-met-omega-prediab-03"
    }
  ],
  "manifest_hash": "sha256:45ce64dae9d7f163db9d57408b5085b0d368ed86656b7bce1e2c4f093d0b2265"
}
